Company
Allterum Therapeutics
- Biotech
Description
Develops 4A10, an anti-CD127 monoclonal antibody for cancers with CD127 expression, aiming to treat acute lymphoblastic leukemia, B-cell malignancies, and lymphomas.
Allterum Therapeutics is located in the Houston ecosystem.
Related
March BiosciencesDevelops clinical-stage CAR-T cell therapies, including MB-105, aimed at difficult hematological cancers, with a focus on relapsed or…
Artiva Biotherapeutics ($ARTV)Develops off-the-shelf, non-genetically modified natural killer cell therapies for deep B-cell depletion, aiming to help patients with…
Sana Biotechnology ($SANA)Builds engineered cell medicines that repair or control genes, or replace damaged cells, for patients with diseases including diabetes,…
OpenwaterDevelops low-cost medical hardware and software using light, sound, and electromagnetics in the body, aiming to treat diseases and support…
Boundless Bio ($BOLD)Develops ecDNA-directed cancer therapies that target vulnerabilities in cancer cells for patients with intractable oncogene-amplified…
Cartesian Therapeutics ($RNAC)Develops clinical-stage mRNA cell therapies designed to treat autoimmune diseases, aiming to expand access to cell therapy for patients…
Caribou Biosciences ($CRBU)Develops genome-edited allogeneic CAR-T cell therapies using CRISPR and chRDNA technology for patients with hematologic malignancies and…
Twist Bioscience ($TWST)Builds synthetic DNA products, gene and oligo pools, NGS target enrichment tools, and antibody engineering services for genomics and…
BigHat BiosciencesDesigns AI-guided antibody therapeutics using automated wet-lab data generation to help drug development teams optimize multiple biological…
BMS Cell Therapy Washington ($BMY)Develops, manufactures, and commercializes cancer immunology and cell therapies for people with difficult-to-treat cancers and other…
BioNTechBioNTech develops investigational therapies for cancer and infectious diseases, including mRNA cancer immunotherapies, immunomodulators,…
Life BiosciencesDevelops epigenetic restoration therapies intended to rejuvenate cells and treat age-related diseases, with an initial clinical trial…